甲氨蝶呤治疗类风湿关节炎患者淋巴增殖性疾病中淋巴细胞计数的不同转变模式
该研究比较了甲氨蝶呤治疗的类风湿关节炎患者中20例自发消退性淋巴增殖性疾病、13例持续性淋巴增殖性疾病及66例无淋巴增殖性疾病对照的临床特征。淋巴增殖性疾病诊断时两组患者淋巴细胞绝对值均显著低于对照组,停用甲氨蝶呤后消退组淋巴细胞快速恢复而持续组无显著增加。诊断时淋巴细胞计数降低及停用甲氨蝶呤后恢复与淋巴增殖性疾病自发消退显著相关。
要点
- 淋巴增殖性疾病诊断时淋巴细胞绝对值显著低于无淋巴增殖性疾病对照。
- 停用甲氨蝶呤后消退组淋巴细胞快速恢复,持续组无显著增加。
- 淋巴细胞计数变化可区分消退性与持续性淋巴增殖性疾病。
核心结论
- 淋巴增殖性疾病诊断时淋巴细胞计数显著降低及停用甲氨蝶呤后恢复与淋巴增殖性疾病自发消退显著相关。
研究设计与样本
- 研究纳入33例甲氨蝶呤治疗期间发生淋巴增殖性疾病的类风湿关节炎患者,其中20例为消退性淋巴增殖性疾病,13例为持续性淋巴增殖性疾病。
- 对照组为66例临床匹配的甲氨蝶呤治疗无淋巴增殖性疾病的类风湿关节炎患者,比较三组临床特征。
主要发现
- 三组间类风湿关节炎临床特征及淋巴增殖性疾病特征无显著差异。
- 淋巴增殖性疾病诊断时消退组淋巴细胞绝对值为497/µl,持续组为680/µl,对照组为1400/µl,两组淋巴增殖性疾病组均显著低于对照组(P < 0.05)。
- 停用甲氨蝶呤后消退组淋巴细胞在第2周快速恢复至1214/µl(P < 0.01),此后维持与对照组相当水平。
- 持续组淋巴细胞在12周内无显著增加(第2周为620/µl,P = 0.57)。
关键数值与推荐
- 淋巴增殖性疾病诊断时淋巴细胞绝对值:消退组497/µl,持续组680/µl,对照组1400/µl(P < 0.05)。
- 停用甲氨蝶呤后第2周淋巴细胞绝对值:消退组1214/µl(P < 0.01),持续组620/µl(P = 0.57)。
临床怎么用
- 甲氨蝶呤治疗期间发生淋巴增殖性疾病时,诊断时淋巴细胞计数降低及停用甲氨蝶呤后快速恢复提示可能自发消退。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To clarify the characteristics of lymphoproliferative disorder (LPD) in patients with RA treated with MTX. METHODS: Among 33 patients developing LPD during MTX treatment, 20 LPDs regressed spontaneously within 12 weeks after MTX cessation (regressive LPD), and 13 did not regress and most of them died or needed chemotherapy (persistent LPD). The control group consisted of 66 clinically matched MTX-treated RA patients without LPD. The clinical characteristics were compared between these three groups. RESULTS: While no significant differences were found in clinical RA and LPD features among the three groups, the absolute lymphocyte number of the two LPD groups at LPD diagnosis was significantly lower than the control group (497/µl in the regressive vs 680/µl in the persistent vs 1400/µl in the control, P < 0.05). After MTX withdrawal, the lymphocyte number in the regressive group rapidly recovered to 1214/µl (P < 0.01) by week 2 and was thereafter maintained at an equivalent level to the control group. In contrast, lymphocyte level in the persistent group did not show significant increase throughout 12 weeks (620/µl at week 2, P = 0.57). Changes in lymphocyte number following MTX withdrawal clearly distinguished the regressive LPD from the persistent LPD. CONCLUSION: A significant decrease in lymphocyte count at the LPD diagnosis and its restoration after MTX withdrawal were markedly associated with spontaneous regression of LPD developing during MTX treatment.
引用
- Saito S, Kaneko Y, Yamaoka K, et al. Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate. Rheumatology (Oxford). 2017. PMID: 28165538. doi:10.1093/rheumatology/kex002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。